CMDE of NMPA on issuing three guidelines for registration review, including nucleic acid detection reagents for novel coronavirus (2019-nCoV) (No. 18 [2022])
- Categories:News
- Author:
- Origin:
- Time of issue:2022-05-10
- Views:0
(Summary description)
CMDE of NMPA on issuing three guidelines for registration review, including nucleic acid detection reagents for novel coronavirus (2019-nCoV) (No. 18 [2022])
(Summary description)
- Categories:News
- Author:
- Origin:
- Time of issue:2022-05-10
- Views:0
In order to further standardize the management of novel coronavirus-related detection reagents, CMDE of NMPA has organized and formulated the Guidelines for the Registration and Review of Nucleic Acid Detection Reagents for Novel Coronavirus (2019-nCoV), the Guidelines for the Registration and Review of Novel Coronavirus (2019-nCoV) Antibody Detection Reagents, and the Guidelines for the Registration and Review of Antigen Detection Reagents for Novel Coronavirus (2019-nCoV) are hereby issued.
Notice is hereby given.
Click here to get more information国家药监局器审中心关于发布新型冠状病毒(2019-nCoV)核酸检测试剂等3项注册审查指导原则的通告(2022年第18号) (cmde.org.cn)
Scan the QR code to read on your phone
Recommended News
Telephones
info@crcs.com.cn
Address
Room 1009, Tower A, Longqin International Building, No. 168, Guang 'anmenwai Street, Xicheng District, Beijing
Company Introduction
The company specializes in medical device registration, in vitro diagnostic reagents registration, cosmetics agent service company, committed to the NMPA, CE regulation research and product registration and certification service has been more than 17 years.
Contact us
Beijing Medical & Care Co. Ltd.